clarithromycin has been researched along with Rodent Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, SE; Brayton, C; Del Carmen Martino-Cardona, M; Watson, J | 1 |
| Pandey, SK; Rizvi, A; Tripathi, R | 1 |
| Bonner, RA; Delaney, KH; Gee, LC; Jury, J; Perdue, MH | 1 |
| Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Vilde, JL | 1 |
1 trial(s) available for clarithromycin and Rodent Diseases
| Article | Year |
|---|---|
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, CD1; Clarithromycin; Complement Factor D; Drug Combinations; Female; Helicobacter; Helicobacter Infections; Immunocompromised Host; Male; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Omeprazole; Rodent Diseases | 2010 |
3 other study(ies) available for clarithromycin and Rodent Diseases
| Article | Year |
|---|---|
Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Topics: Administration, Oral; Animals; Antimalarials; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Dosage Calculations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Malaria; Male; Mefloquine; Mice; Parasitemia; Plasmodium yoelii; Rodent Diseases; Survival Rate; Thailand | 2011 |
Eradication of Helicobacter spp. from a rat breeding colony.
Topics: Amoxicillin; Animal Feed; Animals; Animals, Laboratory; Clarithromycin; DNA Primers; Electrophoresis, Agar Gel; Feces; Helicobacter; Helicobacter Infections; Metronidazole; Omeprazole; Polymerase Chain Reaction; Rats; RNA, Ribosomal, 16S; Rodent Diseases | 2005 |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Rifabutin; Rodent Diseases; Spleen; Time Factors; Tuberculosis | 1993 |